Combined deodorant dispensing container and cap
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a front elevational view of a combined deodorant dispensing container and cap showing our new design;
FIG. 2 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front elevational view of a modified embodiment illustrated in FIG. 1; and,
FIG. 6 is a top plan view of the embodiment of FIG. 5.
Referenced Cited
Patent History
Patent number: D333977
Type: Grant
Filed: Nov 29, 1990
Date of Patent: Mar 16, 1993
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Thomas Gatrost (Randolph, NJ), Natalie Pyden (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Mitchell I. Siegel
Attorney: Morton S. Simon
Application Number: 7/620,589
Type: Grant
Filed: Nov 29, 1990
Date of Patent: Mar 16, 1993
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Thomas Gatrost (Randolph, NJ), Natalie Pyden (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Mitchell I. Siegel
Attorney: Morton S. Simon
Application Number: 7/620,589
Classifications
Current U.S. Class:
D/9337;
D/9529